HCB 101 - hC Bioscience
Alternative Names: HCB-101 - hC BioscienceLatest Information Update: 17 May 2024
At a glance
- Originator hC Bioscience
- Class Antihaemorrhagics; RNA
- Mechanism of Action Factor VIII replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Haemophilia A